021-51111890
购物车（）
sales@molnova.cn
Homo-VK-II-36
CAS No. 1479049-35-8
Homo-VK-II-36 ( Homo VK II 36; HomoVKII36; Homo-V-II-36 )
产品货号. M23634 CAS No. 1479049-35-8
Homo-VK-II-36 is a carvedilol analogue that acts by inhibiting store-?overload-induced calcium release through the RyR2 channel.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1596 | 有现货 |
|
| 10MG | ￥2535 | 有现货 |
|
| 25MG | ￥4317 | 有现货 |
|
| 50MG | ￥6221 | 有现货 |
|
| 100MG | ￥8748 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Homo-VK-II-36
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Homo-VK-II-36 is a carvedilol analogue that acts by inhibiting store-?overload-induced calcium release through the RyR2 channel.
-
产品描述Homo-VK-II-36 is a carvedilol analogue that acts by inhibiting store-?overload-induced calcium release through the RyR2 channel.
-
同义词Homo VK II 36; HomoVKII36; Homo-V-II-36
-
通路Others
-
靶点Other Targets
-
受体RyR2 channel
-
研究领域——
-
适应症——
化学信息
-
CAS Number1479049-35-8
-
分子量460.5
-
分子式C27H28N2O5
-
纯度>98% (HPLC)
-
溶解度DMSO:10 mM
-
SMILESCOC1=CC=CC=C1OCCN2CC(OCC2=O)CCOC3=CC=CC4=C3C5=CC=CC=C5N4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zhang JZ, McLay JC, Jones PP. The arrhythmogenic human HRC point mutation S96A leads to spontaneous Ca(2+) release due to an impaired ability to buffer store Ca(2+). J Mol Cell Cardiol. 2014 Sep;74:22-31. doi: 10.1016/j.yjmcc.2014.04.019. Epub 2014 May 5. PubMed PMID: 24805197.
产品手册
关联产品
-
Quercetin 3,7-digluc...
Quercetin 3,7-diglucoside exhibits antioxidant activity.
-
ML221
ML221 is a potentapelin /APJfunctional antagonist, inhibiting apelin-13-mediated activation of APJ, withIC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, andEC80of 10 nM in both assays.
-
Conduritol A
Conduritol A has a hypoglycemic effect, can have an effect on regulating the metabolism of blood lipid, free-radical scavenging, enhancing the antioxidant ability, potentiating immune function; it also can markedly prevent the diabetic rats from getting cataracts through the inhibition of lens aldose reductase.
